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Abstract
Background:  High participation rates are needed to ensure that breast cancer screening
programs effectively reduce mortality. We identified the determinants of non-participation in a
public breast cancer screening program.
Methods: In this case-control study, 274 women aged 50 to 64 years included in a population-
based mammography screening program were personally interviewed. Socio-demographic
characteristics, health beliefs, health service utilization, insurance coverage, prior mammography
and other preventive activities were examined.
Results:  Of the 192 cases and 194 controls contacted, 101 and 173, respectively, were
subsequently interviewed. Factors related to non-participation in the breast cancer screening
program included higher education (odds ratio [OR] = 5.28; 95% confidence interval [CI95%] =
1.57–17.68), annual dental checks-ups (OR = 1.81; CI95%1.08–3.03), prior mammography at a
private health center (OR = 7.27; CI95% 3.97–13.32), gynecologist recommendation of
mammography (OR = 2.2; CI95%1.3–3.8), number of visits to a gynecologist (median visits by cases
= 1.2, versus controls = 0.92, P = 0.001), and supplemental private insurance (OR = 5.62; CI95% =
3.28–9.6). Among women who had not received a prior mammogram or who had done so at a
public center, perceived barriers were the main factors related to non-participation. Among
women who had previously received mammograms at a private center, supplemental private health
insurance also influenced non-participation. Benign breast symptoms increased the likelihood of
participation.
Conclusion: Our data indicate that factors related to the type of insurance coverage (such as prior
mammography at a private health center and supplemental private insurance) influenced non-
participation in the screening program.
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Background
Breast cancer is the most common cancer among women
in developed countries. A woman in the European Union
(EU) has an 8% probability of developing breast cancer
before the age of 75 and a 2% probability of dying from
the disease [1]. Randomized trials have demonstrated that
mammography screening reduces breast cancer mortality
by 18% to 30% [2]. These findings have led to the imple-
mentation of population-based breast cancer prevention
programs in many countries [3]. However, high rates of
participation among the target population are needed to
achieve the reductions in mortality evidenced by clinical
trials and organized programs [4,5]. Consequently, the
factors that influence women's decisions to participate in
organized programs must be identified.
In Spain, population-based programs for breast cancer
prevention were gradually introduced during the 1990s.
By the end of the decade, organized programs had been
established in all regions of the country. Participation in
this programs has ranged from 50–80% of the target pop-
ulation [6].
Organized programs were not introduced in the Balearic
Islands until 1999. The program target women aged 50 to
64 years and provide mammography screening every two
years, with centralized invitations and recruitment of par-
ticipants. During the first round of the screening program,
the rate of attendance was approximately 65%. As Ciatto
et al [7] reported, the reasons for not responding to an
invitation to mammography screening must be studied in
every context. Factors influencing the decision to undergo
screening may vary depending on the geographical setting
and the organizational aspects of health services in that
region. Spain has a national health system with universal
access across all regions of the country. However, in the
Balearic Islands, 30% of the population has voluntary pri-
vate health insurance. This proportion increases to 50%
among those of the upper social class [8].
Acceptance of mammography may be related to socio-
demographic characteristics such as age or social class
[9,10] or to health service utilization patterns specifically
doctor visits in the previous year, physician recommenda-
tion of mammography and access to a regular source of
health care [11-14]. Adherence to other preventive prac-
tices, benign breast disease or a family history of breast
cancer are also factors often associated with the decision
to undergo preventive mammography [11-13]. Other rea-
sons for non-participation in screening programs include
perceived barriers and a low perception of the breast can-
cer risk [15,16].
Here, we investigate the factors that influence non-partic-
ipation in the breast cancer screening program in the Bal-
earic Islands, a region with a high rate of voluntary private
health insurance.
Methods
A case-control study was conducted among women
invited to participate in the breast cancer early detection
program in Majorca. Cases included women who did not
participate in preventive screening and controls included
women who chose to participate.
Study population
The study population were women aged between 50 and
64 years invited to undergo a preventive mammography
during the second year of the first round of the breast can-
cer screening program (1999 to 2000). Women who had
undergone a mammogram during the previous year, had
been diagnosed with breast cancer, had a mental or phys-
ical handicap or had an unknown address were excluded
from the study. Women were selected from the program
database by simple random sampling (using a table of
random numbers). The sample size was calculated based
on the assumption that 50% of cases were covered by pri-
vate and public health insurance. With a power of 0.80
and an alpha error of 0.05, this yielded a sample size of
150 women per group to detect a minimum odds ratio of
2. It was difficult to contact a large number of women;
hence, potential subjects were over-recruited by 100%.
Replacing subject's criteria was: failure to make contact
after five attempts at different times of day, data errors, ill-
ness or interview refusal. Interview response rates were
higher in the control group than in the case group. Inter-
views were conducted by trained personnel, using a struc-
tured questionnaire and were preceded by a personal
letter. None of the subjects refused an interview once the
appointment had been scheduled. Interviews were per-
formed at the subjects' homes in 2001 and each lasted an
average of 30 minutes.
Variables
The interview assessed: 1)socio-demographic characteris-
tics -age, education, birthplace and area of residence-,
2)benign breast symptoms that were included in a check-
list, 3)family history of breast cancer, 4)preventive activi-
ties -mammography during the past two years, Pap smear
in the past five years and annual dental check-ups-, 5)atti-
tudes towards mammography among family and friends
as suggested by Champion [9], 6)health-service-related
variables -mammography recommendation from family
doctor or gynecologist, use of health services and type of
insurance-, 7)accessibility variables -distance in kilom-
eters to the mammography center and employment sta-
tus-, 8)reasons for not attending the screening. 9)variables
measured by the health belief model scale, which was
developed and validated by Champion [17] and subse-
quently adapted and validated for use in Spain [18].BMC Public Health 2008, 8:387 http://www.biomedcentral.com/1471-2458/8/387
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The health belief model scale has three sub-scales (suscep-
tibility, benefits and barriers) and has been shown to have
high reproducibility, internal consistency and construct
validity. However, none of the three sub-scales have pre-
dictive validity for mammography.
The study protocol was approved by the Research Com-
mittee of the Primary Health Care District.
Statistical analysis
Bivariate analysis was used to assess the relationship
between the variables studied and non-participation in
the screening program. Crude odds ratio (OR) and confi-
dence intervals (CI) for an alpha error of 5% were calcu-
lated by means of logistic regression analysis. Scores on
the health belief sub-scales were compared between the
two groups using the Mann-Whitney U-test.
Multivariate logistic regression analysis was performed,
with the dependent variable defined as non-participation
to the mammography appointment. Independent varia-
bles showing a statistical significance of <0.25 were
selected and backward logistic regression analysis was per-
formed. Possible first-order interactions were assessed in
the final model. The statistical significance of each inter-
action was determined using the likelihood ratio test, with
and without the interaction term. Statistical analyses were
performed using SPSS software, version 11.5.
Results
Two random samples of controls and cases were drawn
from databases comprising 309 and 326 women, respec-
tively. We were able to contact 194 controls (of the 309, 3
lacked telephones and 112 provided incorrect telephone
numbers) and 192 cases (of the 326, 52 lacked telephones
and 82 provided incorrect telephone numbers). There
were no statistically significant differences in the ages of
contacted and non-contacted women. A total of 173
women in the control group were interviewed, with a
response rate of 89.2% (173 of 194). Nineteen of the 173
potential controls refused the interview and 2 could not
be interviewed for other reasons. A total of 101 cases were
interviewed, yielding a response rate of 52.6% (101 of
192). Seven of the 101 potential cases did not meet the
inclusion criteria, 56 could not be located, 22 refused the
interview and 6 could not be interviewed for other rea-
sons. There were no statistically significant differences in
the ages of women who were and were not interviewed.
The characteristics of the cases and controls are summa-
rized in Table 1. Women with higher education levels
were five times more likely not to participate in the screen-
ing program. No statistically significant differences in pro-
gram participation were found in relation to age,
birthplace or employment status.
As described in Table 2, family history of breast cancer was
not associated with participation in the program, nor was
benign breast disease or the degree of mammography
approval among family and friends. Furthermore, we did
not identify a relationship between program participation
and perceived susceptibility to breast cancer, perceived
benefits of mammography or perceived barriers to screen-
ing.
Table 1: Characteristics of attenders and non-attenders to mammography screening program.
Variables Cases Non-attenders, n(%) (n = 101) Controls Attenders, n(%) (n = 173) Crude OR (95% CI)
Age
50–54 14 (13.9) 26 (15.1) 1
55–59 36 (35.6) 69 (40.1) 0.96 (0.45–2.08)
60–65** 51 (50.5) 77 (44.8) 1.23 (0.58–2.57)
Educational level
Illiterate-incomplete primary 15 (14.9) 33 (19.2) 1
Primary education 30 (29.7) 72 (41.9) 0.91 (0.43–1.92)
Secondary education 44 (43.6) 61 (35.5) 1.58 (0.77–3.27)
Higher education 12 (11.9) 5 (3.5) 5.28 (1.57–17.68)*
Place of birth:
Balearic islands 60 (59.4) 110 (63.6) 1
Spain 35 (34.7) 58 (33.5) 1.10 (0.65–1.80)
Others 6 (5.9) 5 (2.9) 2.2 (0.64–7.51)
Working activity
Employed 38 (37.6) 58 (33.5) 1
Unemployed-retired-housewife 63 (62.4) 115 (66.5) 0.83 (0.50–1.39)
*p < 0.01 ** some women had 65 at the moment of the interview.BMC Public Health 2008, 8:387 http://www.biomedcentral.com/1471-2458/8/387
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Table 3 illustrates the distribution of participants and
non-participants, with respect to health behaviors and the
use of health services. Non-participants were more likely
to have undergone annual dental check-ups and prior
mammograms at private facilities, while a history of Pap
smears was not associated with participation. Moreover,
women with voluntary private health insurance were
more likely not to participate in the screening program.
Mammography recommendations from gynecologists
were associated with a lower probability of participation,
whereas receiving a recommendation from a general prac-
titioner (GP) had no influence on attendance. However,
the number of visits to a GP within the previous year was
significantly higher among participants. In contrast, the
number of gynecologist visits was higher among non-par-
ticipants. There were no differences between the two
groups with respect to distance to the mammography
center.
All women provided a reason for not participating, and
three women each provided two answers. Among the rea-
sons for not accepting an invitation to screening (Table 4),
receiving periodic mammography referrals from a private
gynecologist and undergoing a prior mammography that
was covered by private health insurance were the most fre-
quent. Failure to receive the letter of invitation was also
often mentioned.
Our data revealed differences between women with sup-
plemental private health insurance and those with only
public health insurance (Table 5). A larger proportion of
women with supplemental private health insurance had a
Table 2: Participation according to perceived breast cancer risk, health beliefs and relatives attitudes towards mammography
Variables Cases Non-attenders n(%) (n = 101) Controls Attenders n(%) (n = 173) Crude OR (95% CI)
Family history of cancer
No 80 (79.2) 142 (82.1) 1
Yes 21 (20.8) 31 (17.9) 1.2(0.64–2.23)
Benign breast symptoms
No 69 (68.3) 103 (59.5) 1
Yes 32 (31.7) 70 (40.5) 0.68(0.41–1.14)
Attitudes towards mammography
Spouse
Neutral/disapproval/disapproval much 
Approved/
6 (14) 22 (15.9) 1
approved much 37 (86) 116 (84.1) 1.17 (0.44–3.10)
Sons/daughters
Neutral/disapproval/disapproval much 
Approved/
3 (7) 8 (6.3) 1
approved much 40 (93) 120 (93.8) 0.88 (0.22–3.51)
Parents
Neutral/disapproval/disapproval much 
Approved/
3 (20) 6 (21.4) 1
approved much 12 (80) 22 (78.6) 1.09 (0.23–5.16)
Friend
Neutral/disapproval/disapproval much 
Approved/
2 (4.4) 9 (7) 1
approved much 43 (95.6) 119 (93) 1.62 (0.33–7.82)
General practitioner
Neutral/disapproval/disapproval much 
Approved/
2 (7.1) 11 (13.6) 1
approved much 26 (92.9) 70 (86.4) 2.04 (0.42–9.84)
Non-attenders Median (P25–P75) Attenders Median (P25–P75) P*
Health Belief Model Scale
Susceptibility 6.0(3–8) 6.0(3–8) P = 0.7
Benefits 22.0(20–25) 23.0(21–25) P = 0.27
Barriers 16.0(12–20) 16.0(14–20) P = 0.37
* Mann-Whitney U testBMC Public Health 2008, 8:387 http://www.biomedcentral.com/1471-2458/8/387
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higher education level, had received frequent gynecologist
recommendations for mammography, visited a gynecolo-
gist often and had undergone prior mammograms at a pri-
vate facility.
Prior mammograms were identified as an effect modifier
in our multivariate analysis (Table 6); therefore, separate
analyses were performed to assess women who had
undergone prior mammograms at a public center, prior
mammograms at a private center and those who had not
undergone prior mammograms. Among women who had
never undergone a prior mammogram or who had done
so at a public center, the perceived barriers were the main
factors related to non-participation. Among women who
had previously undergone mammograms at a private
center, supplemental private health insurance influenced
non-participation. In this last group, benign breast symp-
toms increased the likelihood of participation.
Discussion
Our findings reveal that private health insurance coverage
is most highly associated with non-participation in a
screening program. This factor interact with the patterns
of preventive health activities shown by women with vol-
untary private insurance, compared with women who
were only covered by public insurance. Women with pri-
vate insurance tended to be more highly educated, attend
gynecologic consultations more often and were more
likely to receive mammography recommendations by a
gynecologist in a private setting that is, outside of the
screening program.
Table 3: Distribution of attenders and non-attenders to mammography screening program according to health services utilisation.
Variables Cases Non-attenders, n(%) (n = 101) Controls Attenders, n(%) (n = 173) Crude OR (95% CI)
Preventive activities
Pap test in last 5 years
No 33(32,7) 69(40.1) 1
Yes 68(67.3) 103(59.9) 1.38 (0.82–2.31)
Annual dental cheks-ups
No 32(31.7) 79(45.7) 1
Yes 69(68.3) 94(54.3) 1.81 (1.08–3.03)
Prior mammography last 2 years
No prior mammograms 30 (29.7) 97 (56.1) 1
Prior mammograms in public centre 8 (7.9) 48 (27.7) 0.53 (0.23–1.26)**
Prior mammograms in private centre 63 (62.4) 28 (16.2) 7.27 (3.97–13.32)**
Type of health insurance coverage
Public health insurance 29 (28.7) 120 (69.4) 1
Public and private health insurance 72 (71.3) 53 (30.6) 5.62 (3.28–9.6)**
Mammography recommended by GPs
No 81 (80.2) 132 (76.7) 1
Yes 20 (19.8) 40 (23.3) 0.81 (0.44–1.49)
Mammography recommended by gynaecologist
No 26 (25.7) 75 (43.6) 1
Yes 75 (74.3) 97 (56.4) 2.2 (1.30–3.82)**
P*
Visit to general practice(last year)
Mean (SD) 6.9 (8.6) 8.5(10.1) 0.03
Median (P25–P75) 3 (1–11) 6 (2–12)
Visit to gynaecologist (last 2 years)
Mean (SD) 1.2 (1.0) 0.9 (1.1) 0.01
Median (P25–P75) 1 (0–2) 1 (0–2)
Distance to mammography(Km)
Mean (SD) 12.1 (13.0) 13.05 (15.5) 0.90
Median (P25–P75) 10 (1–20) 5 (1–23)
* Mann-Whitney U test
**p < 0.001BMC Public Health 2008, 8:387 http://www.biomedcentral.com/1471-2458/8/387
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Limitations of the study
The proportion of successful contacts and interviews was
higher among participants than among non-participants
in the screening program. Previous studies have also
noted a greater difficulty in contacting non-attenders
[7,19,20]. This may have resulted in a selection bias in
which the non-participation factors were overestimated,
because cases who were not interviewed may have pro-
vided different reasons for not participating than cases
who were interviewed. Some of the non-contacted
women may have been seasonal workers because Majorca
is the most popular tourist destination in Spain, and may
have a different socio-economic status compared with
non-seasonal workers. Another limitation inherent in ret-
rospective studies is that attitudes prior to the invitation to
a mammography may have influenced subsequent behav-
ior. In addition, undergoing a prior mammogram may
have altered attitudes and knowledge. The smaller sample
size in this study may have limited to detect any effect of
the independent variables such as age and level of educa-
tion and offers estimated parameters with low precision as
can be observed in the multivariate analysis.
Socio-demographic factors
In this study, highly educated women were less likely to
participate in the screening program than those with a
lower education level. However, it should be considered
that a greater proportion of highly educated women have
supplemental private insurance and may therefore be
more prone to seek preventive services in the private
health care market. Previous studies have suggested that
opportunistic programs or self-referral mammographies
attract women with medium to high levels of education
[11,13,21], whereas organized programs tend to attract
women from lower social classes [10,12,20,22]. However,
other studies have not reported education-related differ-
ences in participation [7,19,20,23-26].
In general, older women are more reluctant to undergo
mammography. These women tend to have a lower per-
ception of their breast cancer risk and display more nega-
tive attitudes towards screening [9]. At the same time,
older women receive less frequent physician recommen-
dations for mammography [27]. This association has pre-
dominantly been reported by studies in areas that lack
organized programs [9,28,29]. However, differences in
participation among the different age groups are reduced
in population-based programs, consistent with the results
of our study [9,22,25,26,30,31]. Recruitment methods
used by organized programs, as well as efforts to ensure
equal access for all eligible women, may foster equal
access for all age groups.
Working outside the home has been linked to participa-
tion in screening programs [11,20,22,27,30]. Similar to
results reported by Ciatto et al., [7] our findings reveal no
differences in participation between working women and
non-working women. It was not possible to assess the dif-
ferences in participation between Spanish women and
women of other nationalities due to the small number of
foreign women included in our study.
Previous experience with breast disease
As previous studies have reported [11,13,26], family
history of breast cancer or benign breast disease are not
related to participation in the program. However,
among women who had previously undergone a mam-
mogram at a private facility, breast symptoms did
prompt a response to the invitation, possibly because
these women wanted to prevent disease. Consistent
with other studies, the distance from a subject's home
to the screening center did not seem to influence partic-
ipation in the program [7,19,23,32]. Our data did not
identify a relationship between participation in the
program and positive reinforcement from family and
Table 4: Principal reasons stated for non-attendance to mammography screening program.
Cause of non-attendance N = 101
No need for screening
A private gynaecologist makes me periodic gynaecological check-ups 24
I already have had a mammography in a private clinic 30
I already have had mammogram in a public health centre 3
I do not need a mammography, I feel well 5
Physical and psychologist barriers
I did not receive the invitation letter 27
The mammography did not fit well in my agenda 9
I was on travel 3
I forgot the appointment 3
I was afraid 2
I felt lazy 2
Number of responses 104BMC Public Health 2008, 8:387 http://www.biomedcentral.com/1471-2458/8/387
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friends, as has been described previously [7,9,30]. The
low response rate to that question may have reflected
limited knowledge regarding relatives' and friends'
opinions about the screening program.
Beliefs
The construct on which health beliefs model is based, the
perceived susceptibility to breast cancer and the perceived
benefits of and barriers to mammography have been
found as predictive of participation. Women who
Table 5: Characteristics of women according to type of health insurance coverage.
Variables Public and private health insurance N (%) Public health insurance N (%) Crude OR (95% CI)
Mammography recommendation by 
gynaecologist.
No 22 (17.6) 79 (53.4) 1
Yes 103 (82.4) 69 (46.6) 5.30 (3.05–9.40)**
Mammography recommendation by GPs
No 100 (80) 113 (76.4) 1
Yes 25 (20) 35 (23.6) 0.80 (0.45–1.44)
Prior mammography last 2 years
No prior mammograms 32 (26.0) 95 (63.8) 1
Prior mammograms in public centre 8 (6.5) 48 (32.2) 0.49 (0.21–1.15)**
prior mammograms in a private centre 83 (67.5) 6 (4.0) 41.06 (16.36–103.8)**
Age
50–54 15 (12) 25 (16.9) 1
55–59 55 (44) 50 (33.8) 1.83 (0.86–3.86)
60–65 55 (44) 73 (49.3) 1.25 (0.6–2.6)
Educational level
Illiterate-incomplete primary 10 (8.1) 38 (25.5) 1
Primary education 39 (31.5) 63 (42.3) 2.35 (1.05–5.25)***
Secondary education 59 (47.6) 46 (30.9) 4.87 (2.19–10.80)**
Higher education 16 (12.9) 2 (1.3) 30.4 (5.97–154.60)**
P*
Visit to GPs(last year)
Mean (SD) 6.9 (8.8) 8.9 (10.2) 0.009
Median (P25–P75) 4 (1–10) 6 (2–12)
Visit to gynaecologist (last 2 years)
Mean (SD) 1.4 (1.1) 0.7 (1.1)
Median (P25–P75) 2 (0–2) 0 (0–1) 0.000
* Mann-Whitney U test
**p < 0.001
***p < 0,05
Table 6: Multiple regression analysis predicting non-participation.
Characteristic Multivariate OR (CI 95%)*
No prior mammograms
n = 125
Prior mammograms in a public centre
n = 56
Prior mammograms in a private centre
n = 87
Benign breast symptoms 0.6 (0.22–1.94) 0.35 (0.05–2.20) 0.33 (0.11–0.99)
Barriers 1.12 (1.03–1.23) 1.19 (1.01–1.41) 0.90 (0.81–1.02)
Public health insurance 1 1 1
Public and private insurance 2.04 (0.77–5.41) 0.36 (0.02–5.88) 14.1 (1.14–174.90)
Age adjusted
*Goodness of fit: no prior mammogram(Hosmer-lemeshow test = 0.701, ROC curve = 0,766); prior mammogram in a public centre(Hosmer-
Lemeshow test = 0.101, ROC curve = 0.708); prior mammogram in private centre (Hosmer-Lemeshow test = 0.511, ROC curve = 0.730).BMC Public Health 2008, 8:387 http://www.biomedcentral.com/1471-2458/8/387
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undergo regular mammograms report fewer barriers and
perceive more benefits from the screening process [9,16].
Non-participation is more common among women with
greater emotional barriers or those who fear that mam-
mography will be painful [32,33]. Some authors [7,33]
have reported higher participation rates among women
with higher knowledge of the usefulness of mammogra-
phy. In our study, none of the dimensions of the scale
were predictive of attendance. However, the barriers seem
to be obstacles for all women except those who had previ-
ously undergone a mammogram at a private facility.
Preventive activities
We observed no differences in participation among
women who reported undergoing regular Pap smear tests
and those who did not; however, annual dental check-ups
were related to non-participation in the program. The
inverse correlation between dental check-ups and partici-
pation in the program may reflect the fact that dental
check-ups are not an included benefit of the public health
care system and are therefore more common among
women with supplemental private health insurance.
Other studies have reported that women who engage in
preventive activities are more likely to accept an invitation
to a screening program [10,13,20,26,30]. These habits
enable women to monitor their own health and offer the
opportunity for periodic contact with health profession-
als.
Health care providers and use of services
Our results show that frequent visits to a gynecologist and
their recommendations for a mammography were associ-
ated with non-participation in the screening program.
Women who had undergone a preventive mammogram at
a private center and those with supplemental insurance
were also less likely to participate. At the same time,
women with supplemental private insurance were more
likely to have attended more gynecologist visits during the
previous 2 years and received mammography recommen-
dations. Hence, these data suggest that supplemental pri-
vate insurance acts as a barrier to participation in
population-based breast cancer prevention programs.
Women with voluntary private insurance use more pre-
ventive services within the private health sector, either of
their own volition or on the recommendation of a gyne-
cologist, but do not often participate in public screening
programs. Other studies have confirmed lower participa-
tion rates among women who visit private gynecologists
more frequently or who have undergone mammograms
outside of a public screening program [33,35].
In the years since the screening program was introduced,
women who usually seek private preventive services have
continued to do so and private doctors continue to recom-
mend mammography out of the program. As the public
screening program relies primarily on the centralized
recruiting of participants, gynecologists in the public sec-
tor may not feel as involved in actively recommending
mammographies and GPs may be delegating this role to
gynecologists [36]. Given that the recommendations of
gynecologists and GPs are key factors that increase partic-
ipation [14,22], these practitioners should be persuaded
to actively recommend participation in the population-
based program. Family doctors should have a more active
role because they have more opportunities to recommend
participation in the screening program during numerous
patient visits over the course of the year.
Sutton et al [25], reported that women who undergo
mammograms outside of a public screening program are,
in fact, following screening recommendations and should
not be a concern. However, it should be noted that organ-
ized programs follow strict quality-control criteria in
order to avoid adverse effects and increase detection rates
[37]. These practices could not be completely assured in
the private sector.
Conclusion
In summary, we have examined the reasons for non-par-
ticipation in a population-based breast cancer prevention
program in a geographical area where many patients are
covered by voluntary private health insurance. These find-
ings have implications for health policies in the region.
Health authorities should encourage health professionals
in the public sector to promote the benefits of population-
based mammography screening programs with estab-
lished quality-assurance criteria. Guidelines should be
disseminated among professionals of the private sector in
order to promote participation of women in the organ-
ized screening program to ensure optimal prevention.
Women should be provided with accurate, balanced
information regarding the advantages and risks of partici-
pation in organized programs.
Abbreviations
(EU): European Union; (GP): General Practitioner
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
ME and JR designed the study, prepared data collection,
did the statistical analysis and wrote the manuscript. AL
did the multivariate analysis and participated in the writ-
ing of manuscript. CSC and FC participated in the design
and data collection and collaborate in writing the discus-
sion and in the review of the manuscript as a whole.
Acknowledgements
This study was carried out with the support of a grant by the Ministry of 
Health, Institute Carlos III number:01/0624, and with a grant of the Spanish BMC Public Health 2008, 8:387 http://www.biomedcentral.com/1471-2458/8/387
Page 9 of 9
(page number not for citation purposes)
Association Against Cancer. We also received the support of the RedIAPP 
(Preventive activities and Health promotion research network, RD06/
0018/0036) recognised by the Instituto Carlos III. We are grateful to Joan 
Llobera, Maria Ramos and Elena Cabeza for their useful comments on the 
manuscript.
References
1. Boyle P, Ferlay J: Cancer incidence and mortality in Europe,
2004.  Ann Oncol 2005, 16:481-488.
2. Who: International Agency for Research on Cancer.  In Hand-
book for Cancer Prevention, Breast Cancer Screening 7th edition. IARC
Press; 2002. 
3. Ballard-Barbash R, Klabunde C, Paci E, Broeders M, Coleman EA,
Fracheboud J, Bouchard F, Rennert G, Shapiro S: Breast cancer
screening in 21 countries: delivery of services, notification of
results and outcomes ascertainment.  Eur J Cancer Prev 1999,
8:417-426.
4. Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA: Role of
detection method in predicting breast cancer survival: anal-
ysis of randomized screening trials.  J Natl Cancer Inst 2005,
97:1195-1203.
5. Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S,
Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A,
Tholin M, Wiege M, Akerlund A, Wu HM, Tung TS, Chiu YH, Huang
CC, Smith RA, Rosén M, Stenbeck M, Holmberg L: The impact of
organized mammography service screening on breast carci-
noma mortality in seven Swedish counties.  Cancer 2002,
95:458-469.
6. Asua BJ: Mammography for breast cancer screening.  Rev Esp
Salud Publica 2005, 79:517-520.
7. Ciatto S, Cecchini S, Isu A, Maggi A, Cammelli S: Determinants of
non-attendance to mammographic screening. Analysis of a
population sample of the screening program in the District
of Florence.  Tumori 1992, 78:22-25.
8. Balearic Island Health Survey (ESIB): Department of Public
Health, Balearic Department of Health and Consumer
Affairs, Palma Majorca.  2001.
9. Champion V: Relationship of age to mammography compli-
ance.  Cancer 1994, 74:329-335.
10. Bancej CM, Maxwell CJ, Onysko J, Eliasziw M: Mammography uti-
lization in Canadian women aged 50 to 69: identification of
factors that predict initiation and adherence.  Can J Public
Health 2005, 96:364-368.
11. Potvin L, Camirand J, Beland F: Patterns of health services utili-
zation and mammography use among women aged 50 to 59
years in the Quebec Medicare system.  Med Care 1995,
33:515-530.
12. Rodriguez C, Plasencia A, Schroeder DG: Predictive factors of
enrollment and adherence in a breast cancer screening pro-
gram in Barcelona (Spain).  Soc Sci Med 1995, 40:1155-1160.
13. Hawley ST, Earp JA, O'Malley M, Ricketts TC: The role of physician
recommendation in women's mammography use: is it a 2-
stage process?  Med Care 2000, 38:392-403.
14. Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML: Fac-
tors associated with women's adherence to mammography
screening guidelines.  Health Serv Res 1998, 33:29-53.
15. Skinner CS, Arfken CL, Sykes RK: Knowledge, perceptions, and
mammography stage of adoption among older urban
women.  Am J Prev Med 1998, 14:54-63.
16. Champion VL, Skinner CS: Differences in perceptions of risk,
benefits, and barriers by stage of mammography adoption.  J
Womens Health (Larchmt) 2003, 12:277-286.
17. Champion VL: Revised susceptibility, benefits, and barriers
scale for mammography screening.  Res Nurs Health 1999,
22:341-348.
18. Esteva M, Ripoll J, Sanchez-Contador C, Collado F, Tebe C, Castano
E, Torrent M: Adaptation and validation of a questionnaire on
susceptibility, benefits and barriers in breast cancer screen-
ing with mammography.  Gac Sanit 2007, 21:282-289.
19. McNoe B, Richardson AK, Elwood JM: Factors affecting participa-
tion in mammography screening.  N Z Med J 1996, 109:359-361.
20. Aro AR, De Koning HJ, Absetz P, Schreck M: Psychosocial predic-
tors of first attendance for organised mammography screen-
ing.  J Med Screen 1999, 6:82-88.
21. Mickey RM, Vezina JL, Worden JK, Warner SL: Breast screening
behavior and interactions with health care providers among
lower income women.  Med Care 1997, 35:1204-1211.
22. Bare ML, Montes J, Florensa R, Sentis M, Donoso L: Factors related
to non-participation in a population-based breast cancer
screening programme.  Eur J Cancer Prev 2003, 12:487-494.
23. Donato F, Bollani A, Spiazzi R, Soldo M, Pasquale L, Monarca S, Lucini
L, Nardi G: Factors associated with non-participation of
women in a breast cancer screening programme in a town in
northern Italy.  J Epidemiol Community Health 1991, 45:59-64.
24. Cabeza E, Esteva M, Pujol A, Thomas V, Sanchez-Contador C: Social
disparities in breast and cervical cancer preventive practices.
Eur J Cancer Prev 2007, 16:372-379.
25. Sutton S, Bickler G, Sancho-Aldridge J, Saidi G: Prospective study
of predictors of attendance for breast screening in inner Lon-
don.  J Epidemiol Community Health 1994, 48:65-73.
26. Lagerlund M, Sparen P, Thurfjell E, Ekbom A, Lambe M: Predictors
of non-attendance in a population-based mammography
screening programme; socio-demographic factors and
aspects of health behaviour.  Eur J Cancer Prev 2000, 9:25-33.
27. O'Malley MS, Earp JA, Hawley ST, Schell MJ, Mathews HF, Mitchell J:
The association of race/ethnicity, socioeconomic status, and
physician recommendation for mammography: who gets the
message about breast cancer screening?  Am J Public Health
2001, 91:49-54.
28. Borras JM, Guillen M, Sanchez V, Junca S, Vicente R: Educational
level, voluntary private health insurance and opportunistic
cancer screening among women in Catalonia (Spain).  Eur J
Cancer Prev 1999, 8:427-434.
29. Lorant V, Boland B, Humblet P, Deliege D: Equity in prevention
and health care.  J Epidemiol Community Health 2002, 56:510-516.
30. Seow A, Straughan PT, Ng EH, Emmanuel SC, Tan CH, Lee HP: Fac-
tors determining acceptability of mammography in an Asian
population: a study among women in Singapore.  Cancer
Causes Control 1997, 8:771-779.
31. Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, Bull D,
Reeves G, English R, Taylor S, Elliman J, Lole Harris C: Comparison
of various characteristics of women who do and do not
attend for breast cancer screening.  Breast Cancer Res 2002,
4:R1.
32. Lagerlund M, Hedin A, Sparen P, Thurfjell E, Lambe M: Attitudes,
beliefs, and knowledge as predictors of nonattendance in a
Swedish population-based mammography screening pro-
gram.  Prev Med 2000, 31:417-428.
33. Aro AR, De Koning HJ, Absetz P, Schreck M: Two distinct groups
of non-attenders in an organized mammography screening
program.  Breast Cancer Res Treat 2001, 70:145-153.
34. Alcaraz M, Lluch A, Miranda J, Pereiro I, Salas MD: [Study of non-
participation in the breast cancer screening program in the
city of Valencia (Spain)].  Gac Sanit 2002, 16:230-235.
35. Hemminki E, Sevon T, Tanninen K, Pukkala E, Anttila A: Use of pri-
vate gynaecologist does not relate to better prevention out-
comes – an ecological analysis from Finland.  BMC Health Serv
Res 2006, 6:27.
36. Wallace AE, Mackenzie TA, Weeks WB: Women's primary care
providers and breast cancer screening: who's following the
guidelines?  Am J Obstet Gynecol 2006, 194:744-748.
37. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von KL:
European guidelines for quality assurance in breast cancer
screening and diagnosis. Fourth edition-summary docu-
ment.  Ann Oncol 2008, 19:614-22.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/8/387/pre
pub